NewsRx

Search our medical news database

Mergers & Acquisitions

Biosite Announces Regulatory Clearance in Germany of Beckman Coulter Tender Offer

Published in Healthcare Mergers, Acquisitions and Ventures Week, May 12th, 2007

Biosite Incorporated (NASDAQ:BSTE) announced that Beckman Coulter, Inc. (NYSE:BEC) has obtained clearance from the German Federal Cartel Office (the Bundeskartellamt) in connection with its proposed acquisition of Biosite pursuant to the tender offer described below.

The tender offer is conditioned upon at least a majority of the outstanding Biosite shares, determined on a fully diluted basis, being tendered, as well as the satisfaction of other customary conditions. Approval of the transaction by Beckman Coulter's shareholders is not required.

As previously announced, a subsidiary of Beckman Coulter has commenced a cash tender offer to acquire all...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now



NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook